L. Visentin

600 total citations
7 papers, 209 citations indexed

About

L. Visentin is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, L. Visentin has authored 7 papers receiving a total of 209 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Cellular and Molecular Neuroscience and 1 paper in Surgery. Recurrent topics in L. Visentin's work include Mitochondrial Function and Pathology (2 papers), ATP Synthase and ATPases Research (2 papers) and Particle physics theoretical and experimental studies (1 paper). L. Visentin is often cited by papers focused on Mitochondrial Function and Pathology (2 papers), ATP Synthase and ATPases Research (2 papers) and Particle physics theoretical and experimental studies (1 paper). L. Visentin collaborates with scholars based in Italy and United States. L. Visentin's co-authors include Carlo Farina, Maxine Gowen, Paola Misiano, Maurizio Valente, Robert A. Dodds, Jeremy N. Bradbeer, X.G. Liang, Silvano Ronzoni, Vittorio Vecchietti and Paola Petrillo and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Medicinal Chemistry and European Journal of Clinical Investigation.

In The Last Decade

L. Visentin

7 papers receiving 191 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Visentin Italy 6 140 48 48 29 26 7 209
Timothy J. Blackburn United States 10 148 1.1× 8 0.2× 32 0.7× 36 1.2× 5 0.2× 16 328
David Duncan United States 9 54 0.4× 8 0.2× 23 0.5× 40 1.4× 2 0.1× 27 251
Julien Viotti France 9 76 0.5× 33 0.7× 71 1.5× 17 0.6× 15 256
Keqiang Ma China 7 60 0.4× 10 0.2× 49 1.0× 25 0.9× 3 0.1× 25 173
Derina E. Sweeney United States 11 252 1.8× 11 0.2× 69 1.4× 54 1.9× 2 0.1× 12 366
José Antonio Bernal Spain 6 99 0.7× 12 0.3× 7 0.1× 22 0.8× 2 0.1× 11 187
Yuqi Wu China 10 48 0.3× 9 0.2× 77 1.6× 19 0.7× 34 243
Claudio Arrigoni Italy 5 65 0.5× 15 0.3× 37 0.8× 15 0.5× 3 0.1× 13 148
Anli Shu China 6 168 1.2× 5 0.1× 41 0.9× 18 0.6× 3 0.1× 9 280
Matthew Lane United States 6 32 0.2× 19 0.4× 25 0.5× 16 0.6× 6 0.2× 8 155

Countries citing papers authored by L. Visentin

Since Specialization
Citations

This map shows the geographic impact of L. Visentin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Visentin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Visentin more than expected).

Fields of papers citing papers by L. Visentin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Visentin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Visentin. The network helps show where L. Visentin may publish in the future.

Co-authorship network of co-authors of L. Visentin

This figure shows the co-authorship network connecting the top 25 collaborators of L. Visentin. A scholar is included among the top collaborators of L. Visentin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Visentin. L. Visentin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Misiano, Paola, et al.. (2003). Antagonism between the Anti-Inflammatory Activity of the Cannabinoid WIN 55212-2 and SR 141716A. Pharmacology. 69(3). 158–163. 8 indexed citations
2.
Farina, Carlo, Stefania Gagliardi, Carlo Parini, et al.. (2001). Novel bone antiresorptive agents that selectively inhibit the osteoclast V-H+-ATPase. Il Farmaco. 56(1-2). 113–116. 20 indexed citations
3.
Visentin, L., Robert A. Dodds, Maurizio Valente, et al.. (2000). A selective inhibitor of the osteoclastic V-H+-ATPase prevents bone loss in both thyroparathyroidectomized and ovariectomized rats. Journal of Clinical Investigation. 106(2). 309–318. 100 indexed citations
4.
Dondio, Giulio, Silvano Ronzoni, Drake S. Eggleston, et al.. (1997). Discovery of a Novel Class of Substituted Pyrrolooctahydroisoquinolines as Potent and Selective δ Opioid Agonists, Based on an Extension of the Message−Address Concept. Journal of Medicinal Chemistry. 40(20). 3192–3198. 46 indexed citations
5.
Dondio, Giulio, Geoffrey D. Clarke, Giuseppe Giardina, et al.. (1995). THE ROLE OF THE “SPACER" IN THE OCTAHYDROISOQUINOLINE SERIES: DISCOVERY OF SB 213698, A NON-PEPTIDIC, POTENT AND SELECTIVE DELTA OPIOID AGONIST. 1(4). 394–399. 9 indexed citations
6.
Ceolin, M. Baldo, P. Benetti, F. Bobisut, et al.. (1992). Performance of the N- $$\overline N $$ scintillation counters trigger and TOF systemscintillation counters trigger and TOF system. Nuovo cimento della Società italiana di fisica. A, Nuclei, particles and fields. 105(11). 1679–1690. 3 indexed citations
7.
Fabris, F., Alessandra Casonato, L. Visentin, et al.. (1983). Normal and low molecular weight heparins: interaction with human platelets. European Journal of Clinical Investigation. 13(2). 135–139. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026